Hussnain S. Mirza, MD. MBA (he/him/his)

Associate Professor Pediatrics
Advent Health for Children/ UCF College of Medicine
Orlando, Florida, United States

Presentation(s):

• Inhaled Nitric Oxide (iNO) Treatment of Early Pulmonary Hypertension to Reduce the Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants: A Masked Randomized Controlled Trial

  Saturday, April 26, 2025
  7:45am – 8:00am HST

  Disclosure(s): I do not have any relevant financial / non-financial relationships with any proprietary interests.